Posos, a clinical decision support platform founded in 2017, secured growth financing to enhance its commercial development and expand its user base among healthcare professionals.
Target Information
Posos, founded in 2017 by pharmacist Emmanuel Bilbault and information systems engineer Benjamin Grelié, has developed an innovative clinical decision support platform. After three years of rigorous research and development, the company has harnessed proprietary NLP technology and a cross-referencing search engine to create a solution that provides healthcare professionals with quick and accurate information on drug prescriptions. This is essential for optimal clinical decision-making, enabling physicians to research multiple medications concurrently and to contextualize their responses based on specific patient data.
As a certified medical device, Posos is now utilized by over 85,000 healthcare professionals across five countries. Its solution is seamlessly integrated with popular hospital management software systems, including Hospital Manager, Mediboard, Direct-Consult, Orbis, DxCare, and Diane. This widespread adoption demonstrates the platform's reliability and relevance in today's healthcare landscape.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
Posos operates within the rapidly evolving digital services and retail finance sectors of the healthcare industry. The digital health market is expanding, driven by technological advancements, increasing healthcare costs, and
Similar Deals
ARCHIMED → RehabWorks and Primo Group s.r.l.
2023
Prosperity7 Ventures → Insilico Medicine
2023
PC Capital Development Fund II, L.P. → Polar
2023
Not specified
invested in
Posos
in 2023
in a Growth Equity & Expansion Capital deal